Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2019

Open Access 01-12-2019 | Aneurysm | Research

Demography of vascular Behcet’s disease with different gender and age: an investigation with 166 Chinese patients

Authors: Yong Chen, Jian-Fei Cai, Chen-Hong Lin, Jian-Long Guan

Published in: Orphanet Journal of Rare Diseases | Issue 1/2019

Login to get access

Abstract

Background

The Clinical features of vascular Behcet’s disease (BD) are not well understood because there are few studies. Our study aimed to investigate characteristics of vascular BD in both genders in different age groups.

Results

We enrolled 923 patients with BD who presented to our hospital with adequate medical histories and proper vascular screening exams. The raw incidence rate of vascular BD was 17.98% (166/923). The ratio of vascular BD in male to female patients was 1.868 (p = 0.0004, 95% confidence interval (CI): 1.317 to 2.625). There was a tendency towards higher ESR and CRP in vascular BD patients than in mucocutaneous, but the difference was not significant. The most susceptible affected vessels were cerebral (29.6% in males, 59.4% in females) and lower limb vessels (31.2% in males, and 17.2% in females). The incidence of vascular involvement in younger (< 50 years old) and older (≥ 50 years old) patients were similar, with ratios of 16.58% (122/736) and 23.53% (44/187) respectively. However, in females, younger patients were less likely to have vascular involvement than were older patients (11.43% vs. 20% p = 0.0328, OR: 0.5161, 95% CI: 0.2874 to 0.912). Aneurysm or pseudoaneurysm was diagnosed in 1.84% (17/923) patients, mostly in male patients (p < 0.05, OR: 3.221, 95% CI: 1.097 to 9.112). Twenty vascular BD patients were followed up, and the age at BD diagnosis was 33.23 ± 11.56 year. This did not differ statistically with their age at vascular involvement (36.15 ± 9.52 years). Ages of vascular BD patients did not differ significantly from those of mucocutaneous BD patients (n = 143) in both males and females.

Conclusion

Vascular BD, including lethal types of aneurysm is more likely to occur in male patients. The female patients has a similar incidence rate with the males in their postmenopausal age. There was no evidence of progression course from mucocutaneous BD to vascular involvement.
Literature
1.
go back to reference Davatchi F, Shahram F, Chamsdavatchi C, et al. Behcet's disease: from east to west. Clin Rheumatol. 2010;29(8):823–33.CrossRef Davatchi F, Shahram F, Chamsdavatchi C, et al. Behcet's disease: from east to west. Clin Rheumatol. 2010;29(8):823–33.CrossRef
2.
go back to reference Chen Y, Luo D, Cai JF, Lin CH, Shen Y, Zou J, Guan JL. Effectiveness and safety of Glycyrrhizae Decoction for Purging Stomach-Fire in Behcet disease patients: Study protocol for a randomized controlled and double-blinding trail. Medicine. 2018;97(13):e265.CrossRef Chen Y, Luo D, Cai JF, Lin CH, Shen Y, Zou J, Guan JL. Effectiveness and safety of Glycyrrhizae Decoction for Purging Stomach-Fire in Behcet disease patients: Study protocol for a randomized controlled and double-blinding trail. Medicine. 2018;97(13):e265.CrossRef
3.
go back to reference Ambrose NL, Haskard DO. Differential diagnosis and management of Beh?Et syndrome. Nat Rev Rheumatol. 2013;9(2):79–89.CrossRef Ambrose NL, Haskard DO. Differential diagnosis and management of Beh?Et syndrome. Nat Rev Rheumatol. 2013;9(2):79–89.CrossRef
4.
go back to reference Chen Y, Cui JS, Cai JF, Zou J, Guan JL. Surgical intervention for Behcet's Disease with aorta aneurysm and Pseudoaneurysm: opposite outcomes in two cases. Chinese Med J-Peking. 2017;130(20):2503.CrossRef Chen Y, Cui JS, Cai JF, Zou J, Guan JL. Surgical intervention for Behcet's Disease with aorta aneurysm and Pseudoaneurysm: opposite outcomes in two cases. Chinese Med J-Peking. 2017;130(20):2503.CrossRef
5.
go back to reference Chen Y, Guan JL. Is warfarin indicated in Behcet's syndrome associated with thrombosis? Reflections on treatment and death of a patient. Chinese Med J-Peking. 2018;131(1):105–6.CrossRef Chen Y, Guan JL. Is warfarin indicated in Behcet's syndrome associated with thrombosis? Reflections on treatment and death of a patient. Chinese Med J-Peking. 2018;131(1):105–6.CrossRef
6.
go back to reference Chen Y, Shen Y, Ma HF, et al. Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: a case report. Medicine. 2017;96(50):e9202.CrossRef Chen Y, Shen Y, Ma HF, et al. Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: a case report. Medicine. 2017;96(50):e9202.CrossRef
7.
go back to reference Koç Y, Güllü I, Akpek G, et al. Vascular involvement in Behcet’s disease. Japanese J Med. 1992;40(3):402–10. Koç Y, Güllü I, Akpek G, et al. Vascular involvement in Behcet’s disease. Japanese J Med. 1992;40(3):402–10.
8.
go back to reference Tohmé A, Aoun N, Elrassi B, Ghayad E. Vascular manifestations of Behcet's disease. Eighteen cases among 140 patients. Joint Bone Spine. 2003;70(5):384–9.CrossRef Tohmé A, Aoun N, Elrassi B, Ghayad E. Vascular manifestations of Behcet's disease. Eighteen cases among 140 patients. Joint Bone Spine. 2003;70(5):384–9.CrossRef
9.
go back to reference Chen Y, Liu W, Zou J, Luo D, Cai J, Guan JL. Intestinal pathological changes in Behcet's disease: a clinical retrospective study. Fudan J Med Sci. 2017;44(2):37–41. Chen Y, Liu W, Zou J, Luo D, Cai J, Guan JL. Intestinal pathological changes in Behcet's disease: a clinical retrospective study. Fudan J Med Sci. 2017;44(2):37–41.
10.
go back to reference Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl J Med. 2000;342(12):836–43.CrossRef Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl J Med. 2000;342(12):836–43.CrossRef
11.
go back to reference Alhurani RE, Chahal CA, Ahmed AT, Mohamed EA, Miller VM. Sex hormone therapy and progression of cardiovascular disease in menopausal women. Clin Sci. 2016;130(13):1065–74.CrossRef Alhurani RE, Chahal CA, Ahmed AT, Mohamed EA, Miller VM. Sex hormone therapy and progression of cardiovascular disease in menopausal women. Clin Sci. 2016;130(13):1065–74.CrossRef
12.
go back to reference Clarke R, Collins R, Lewington S, et al. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. Jama. 2002;288(16):2015–22.CrossRef Clarke R, Collins R, Lewington S, et al. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. Jama. 2002;288(16):2015–22.CrossRef
13.
go back to reference Ozdemir R, Barutcu I, Sezgin AT, et al. Vascular endothelial function and plasma homocysteine levels in Behcet’s disease. Am J Cardiol. 2004;94(4):522–5.CrossRef Ozdemir R, Barutcu I, Sezgin AT, et al. Vascular endothelial function and plasma homocysteine levels in Behcet’s disease. Am J Cardiol. 2004;94(4):522–5.CrossRef
14.
go back to reference La RM, Orlandini FD, Dentali F. Homocysteine in vascular Behcet disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2010;30(10):2067–74.CrossRef La RM, Orlandini FD, Dentali F. Homocysteine in vascular Behcet disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2010;30(10):2067–74.CrossRef
15.
go back to reference Dimitrova KR, Degroot K, Myers AK, Kim YD. Estrogen and homocysteine. Cardiovasc Res. 2002;53(3):577–88.CrossRef Dimitrova KR, Degroot K, Myers AK, Kim YD. Estrogen and homocysteine. Cardiovasc Res. 2002;53(3):577–88.CrossRef
16.
go back to reference Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res. 2002;53(3):605–19.CrossRef Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res. 2002;53(3):605–19.CrossRef
17.
go back to reference Disease ISGF. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335(8697):1078–80. Disease ISGF. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335(8697):1078–80.
18.
go back to reference Arayssi T, Hamdan A. New insights into the pathogenesis and therapy of Behcet's disease. Curr Opin Pharmacol. 2004;4(2):183–8.CrossRef Arayssi T, Hamdan A. New insights into the pathogenesis and therapy of Behcet's disease. Curr Opin Pharmacol. 2004;4(2):183–8.CrossRef
19.
go back to reference Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement. Int J Dermatol. 2009;48(3):259–64.CrossRef Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement. Int J Dermatol. 2009;48(3):259–64.CrossRef
Metadata
Title
Demography of vascular Behcet’s disease with different gender and age: an investigation with 166 Chinese patients
Authors
Yong Chen
Jian-Fei Cai
Chen-Hong Lin
Jian-Long Guan
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2019
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-019-1061-1

Other articles of this Issue 1/2019

Orphanet Journal of Rare Diseases 1/2019 Go to the issue